Saskia E.M. Schols

Internist-hematologist
Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands
Nijmegen, Gelderland, Netherlands

Presentation(s):

• OC 01.5 - People with mild hemophilia are at risk of joint disease: the nationwide cohort HiN-6 Study

  Saturday, June 22, 2024
  14:00 – 14:15 ICT

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0279 - Feasibility, measurement properties and relevance of generic PROMIS item banks in adults with von Willebrand disease, platelet function disorders, and rare bleeding disorders

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0280 - Patient perspective of the burden and severity of von Willebrand disease

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 39.5 - Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin deficient patients: Data from the RBiN study

  Monday, June 24, 2024
  10:30 – 10:45 ICT

• PB1198 - Interference of Edoxaban in coagulation factor and inhibitor testing

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 61.2 - Determinants of successful immune tolerance induction in people with severe hemophilia A

  Tuesday, June 25, 2024
  15:00 – 15:15 ICT